Prostate Cancer - Results from #840

REVIEW UroToday

The Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial: Lower baseline prostate-specific antigen Is associated with a greater overall survival benefit from sipuleucel-T, "Beyond the Abstract," by Philip W. Kantoff, MD October 28, 2013

Detection and characterisation of prostate cancer through transrectal quantitative shear wave elastography, "Beyond the Abstract," by Sarfraz Ahmad, MBBS, PhD, MRCSI, MRCSEd October 21, 2013

Vesicocutaneous fistula following adjuvant radiotherapy for pelvic malignancies, "Beyond the Abstract," by Derek B. Hennessey, MB, BAO, BCh, BMedSci, MRCSI, et al October 17, 2013

PSA and galectin-3 -- complementary markers for prostate cancer? "Beyond the Abstract," by Avraham Raz, PhD, et al October 16, 2013

The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors, "Beyond the Abstract," by Ryan P. Kopp, MD and J. K. Parsons, MD, MHS October 14, 2013

Cultural health beliefs and their impact on prostate cancer screening behavior in an underserved immigrant group, "Beyond the Abstract," by Yunkyung Jung, PhD and Hee Yun Lee, PhD October 12, 2013

Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences, "Beyond the Abstract," by Oguz Akin, MD October 10, 2013

Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France, "Beyond the Abstract," by Bernard Malavaud, MD, PhD October 10, 2013

The protective role of vitamin D against the changes in bone mineral density in men starting androgen deprivation therapy, "Beyond the Abstract," by Shabbir M.H. Alibhai, MD, MSc, FRCP(C), et al October 8, 2013

Chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer: Long-term follow-up of a phase II trial, "Beyond the Abstract," by Mari Nakabayashi, MD, PhD and Mary-Ellen Taplin, MD October 4, 2013

The use of a transperineal polyethylene glycol hydrogel spacer to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy, "Beyond the Abstract," by Nadine Beydoun September 30, 2013

A genomic prostate cancer test holds promise to better classify men post-radical prostatectomy for postoperative treatment decisions, "Beyond the Abstract," by Ketan K. Badani, MD September 26, 2013

A novel interplay between Rap1 and PKA regulates induction of angiogenesis in prostate cancer, "Beyond the Abstract," by Eugene Choi and Marsha Rich Rosner September 17, 2013

Can multiparametric MR imaging help identify prostate cancer patients who are candidates for active surveillance? "Beyond the Abstract," by Peter Choyke, MD and Baris Turkbey, MD September 16, 2013

In association with ERG status, Chinese and Western prostate cancers show alternate pathogenetic pathways, "Beyond the Abstract," by Liyan Xue, MD, PhD and Yong-Jie Lu, MD, PhD September 12, 2013

Is it possible for testosterone to have a therapeutic role in prostate cancer? "Beyond the Abstract," by Konstantinos Stamatiou September 12, 2013

High intensity focused ultrasound therapy for localized prostate cancer: Evolution and outcomes over 15 years, "Beyond the Abstract," by Christian G. Chaussy, MD, HonFRCSEd September 11, 2013

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence, "Beyond the Abstract," by Winston W. Tan, MD September 10, 2013

Perineural invasion as a predictor of extraprostatic extension of prostate cancer, "Beyond the Abstract," by Gabriele Cozzi, MD August 28, 2013

Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer, "Beyond the Abstract," by Kwang Hyun Kim, MD and Koon Ho Rha, MD, PhD August 28, 2013

Page 43 of 57